Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation-Reference-Cited by-同舟云学术

Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation

Published:2016-12-15 Issue:11 Volume:47 Page:1093-1101
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Omichi Kiyohiko¹,Akamatsu Nobuhisa¹,Mori Kazuhiro¹,Togashi Junichi¹,Arita Junichi¹,Kaneko Junichi¹,Hasegawa Kiyoshi¹,Sakamoto Yoshihiro¹,Kokudo Norihiro¹

Affiliation:

1. Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine; The University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12845/fullpdf

Reference31 articles.

1. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

2. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

3. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up;Neumann;Transplantation,2004

4. Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience;Tamura;Transpl Int,2010

5. American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents;Journal of Gastrointestinal Surgery;2018-04-20

2. Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience;Clinical Transplantation;2017-09-24

3. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis;Hepatitis Monthly;2017-06-17

4. Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation;Clinical Journal of Gastroenterology;2017-02-21